Pathology · Hematological Malignancies (Leukemias, Lymphomas, Myeloma)

A 70-year-old man presents with fatigue, recurrent infections, and lymphocytosis of 80 × 10⁹/L. Peripheral blood shows small, mature-appearing lymphocytes with frequent smudge (basket) cells. Flow cytometry shows CD5+, CD19+, CD20(dim)+, CD23+. The cytogenetic finding that confers the BEST prognosis in this disease is:

  • A Deletion 17p (TP53)
  • B Deletion 13q14 (miR-15a/16)
  • C Deletion 11q (ATM)
  • D Trisomy 12
Correct answer: B. Deletion 13q14 (miR-15a/16)

Explanation

This is chronic lymphocytic leukemia (CLL), characterized by the CD5+/CD19+/CD23+ phenotype and smudge cells on peripheral smear. The Dohner hierarchical model ranks del(13q14) as the best-prognosis cytogenetic finding in CLL (median survival >10 years), because it only inactivates tumor suppressor miRNAs (miR-15a, miR-16-1). Deletion 17p (TP53) carries the worst prognosis and predicts resistance to chemoimmunotherapy; del(11q) and trisomy 12 are intermediate.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs

See all Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs →